Knott David M Jr United Therapeutics Corp Transaction History

Knott David M Jr

  • $285 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$211.82 - $248.24 $1.9 Million - $2.22 Million
8,949 New
8,949 $2.02 Million
Q2 2022

Aug 11, 2022
SELL
$174.81 - $241.14 $591,382 - $815,776
-3,383 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$184.32 - $216.08 $623,554 - $730,998
3,383 New
3,383 $731,000

Others Institutions Holding UTHR

# of Institutions
673
Shares Held
42.2M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Knott David M Jr Portfolio

Follow Knott David M Jr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

News

Stay updated on Knott David M Jr with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email